MicroRNA‑191 targets CCAAT/enhanced binding protein β and functions as an oncogenic molecule in human non‑small cell lung carcinoma cells

Li,Fuliang; Wen,Jingjing; Shi,Jinsheng; Wang,Yun; Yang,Feifei; Liu,Chunying

doi:10.3892/etm.2019.7668

MicroRNA‑191 targets CCAAT/enhanced binding protein β and functions as an oncogenic molecule in human non‑small cell lung carcinoma cells

Authors:
- Fuliang Li
- Jingjing Wen
- Jinsheng Shi
- Yun Wang
- Feifei Yang
- Chunying Liu
View Affiliations

Affiliations: Department of Pathology, Anqiu People's Hospital, Anqiu, Shandong 262100, P.R. China, Department of Pathology, Weifang Yidu Central Hospital, Weifang, Shandong 262500, P.R. China, Department of B‑ultrasound, Anqiu People's Hospital, Anqiu, Shandong 262100, P.R. China
Published online on: June 13, 2019 https://doi.org/10.3892/etm.2019.7668
Pages: 1175-1183
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aberrant expression of microRNAs (miRs) may be involved in tumor growth and progression in human non‑small cell lung carcinoma (NSCLC). The present study aimed to investigate the potential roles of miR‑191 in NSCLC. Western blotting and reverse transcription‑quantitative polymerase chain reaction were performed to assess protein and/or mRNA levels. Scratch wound healing and transwell assays were performed to determine the NSCLC cell migration and invasion. A luciferase demonstrated that CCAAT/enhanced binding protein β (C/EBPβ) was a target of miR‑191. Previously, miR‑191 has been reported to act as an oncogenic player in multiple human cancers. C/EBPβ has been identified as a target gene of miR‑191; however, the roles and underlying mechanisms of miR‑191 associated with the regulation of tumor invasion in NSCLC remain unknown. In the present study, it was demonstrated that miR‑191 expression levels were higher in human NSCLC tumors compared with in normal adjacent tissue and elevated miR‑191 expression levels were closely associated with tumor node metastasis stage in patients with NSCLC. Furthermore, transfection with miR‑191 mimic inhibited C/EBPβ expression at the mRNA and protein levels and promoted A549 cell migration and invasion. C/EBPβ was reported to be the direct target gene of miR‑191 using a dual luciferase reporter assay. Finally, C/EBPβ siRNA can mimic the effects of miR‑191. These findings indicated that miR‑191 may function as an oncogene in NSCLC, at least partially due to its negative regulatory on C/EBPβ.

View Figures

View References

1	Cui LH, Xu HR, Yang W and Yu LJ: lncRNA PCAT6 promotes non-small cell lung cancer cell proliferation, migration and invasion through regulating miR-330-5p. Onco Targets Ther. 11:7715–7724. 2018. View Article : Google Scholar : PubMed/NCBI
2	Li J and Wei L: Increased expression of LINC01510 predicts poor prognosis and promotes malignant progression in human non-small cell lung cancer. Biomed Pharmacother. 109:519–529. 2019. View Article : Google Scholar : PubMed/NCBI
3	Wang B, Lv K, Chen W, Zhao J, Luo J, Wu J, Li Z, Qin H, Wong TS, Yang W, et al: miR-375 and miR-205 regulate the invasion and migration of laryngeal squamous cell carcinoma synergistically via AKT-mediated EMT. Biomed Res Int. 2016:96527892016. View Article : Google Scholar : PubMed/NCBI
4	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
5	He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
6	Lages E, Ipas H, Guttin A, Nesr H, Berger F and Issartel JP: MicroRNAs: Molecular features and role in cancer. Front Biosci (Landmark Ed). 17:2508–2540. 2012. View Article : Google Scholar : PubMed/NCBI
7	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
8	Nagpal N, Ahmad HM, Molparia B and Kulshreshtha R: MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis. 34:1889–1899. 2013. View Article : Google Scholar : PubMed/NCBI
9	Shi X, Su S, Long J, Mei B and Chen Y: MicroRNA-191 targets N-deacetylase/N-sulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803. Acta Biochim Biophys Sin (Shanghai). 43:849–856. 2011. View Article : Google Scholar : PubMed/NCBI
10	Liu H, Xu XF, Zhao Y, Tang MC, Zhou YQ, Lu J and Gao FH: MicroRNA-191 promotes pancreatic cancer progression by targeting USP10. Tumour Biol. 35:12157–12163. 2014. View Article : Google Scholar : PubMed/NCBI
11	Elyakim E, Sitbon E, Faerman A, Tabak S, Montia E, Belanis L, Dov A, Marcusson EG, Bennett CF, Chajut A, et al: hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 70:8077–8087. 2010. View Article : Google Scholar : PubMed/NCBI
12	Qin S, Zhu Y, Ai F, Li Y, Bai B, Yao W and Dong L: MicroRNA-191 correlates with poor prognosis of colorectal carcinoma and plays multiple roles by targeting tissue inhibitor of metalloprotease 3. Neoplasma. 61:27–34. 2014. View Article : Google Scholar : PubMed/NCBI
13	Li H, Zhou ZQ, Yang ZR, Tong DN, Guan J, Shi BJ, Nie J, Ding XT, Li B, Zhou GW and Zhang ZY: MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma. Hepatology. 66:136–151. 2017. View Article : Google Scholar : PubMed/NCBI
14	Cruz-Munoz W and Khokha R: The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci. 45:291–338. 2008. View Article : Google Scholar : PubMed/NCBI
15	Robinson GW, Johnson PF, Hennighausen L and Sterneck E: The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev. 12:1907–1916. 1998. View Article : Google Scholar : PubMed/NCBI
16	Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ and Rosen JM: C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev. 12:1917–1928. 1998. View Article : Google Scholar : PubMed/NCBI
17	Smink JJ, Bégay V, Schoenmaker T, Sterneck E, de Vries TJ and Leutz A: Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB. EMBO J. 28:1769–1781. 2009. View Article : Google Scholar : PubMed/NCBI
18	Wethmar K, Bégay V, Smink JJ, Zaragoza K, Wiesenthal V, Dörken B, Calkhoven CF and Leutz A: C/EBPbetaDeltauORF mice-a genetic model for uORF-mediated translational control in mammals. Genes Dev. 24:15–20. 2010. View Article : Google Scholar : PubMed/NCBI
19	Zhang XF, Li KK, Gao L, Li SZ, Chen K, Zhang JB, Wang D, Tu RF, Zhang JX, Tao KX, et al: miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ. Oncotarget. 6:4144–4158. 2015.PubMed/NCBI
20	Sundfeldt K, Ivarsson K, Carlsson M, Enerbäck S, Janson PO, Brännström M and Hedin L: The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: Specific increase in C/EBPbeta during epithelial tumour progression. Br J Cancer. 79:1240–1248. 1999. View Article : Google Scholar : PubMed/NCBI
21	Barakat DJ, Zhang J, Barberi T, Denmeade SR, Friedman AD and Paz-Priel I: CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells. Oncogene. 34:5912–5922. 2015. View Article : Google Scholar : PubMed/NCBI
22	Aguilar-Morante D, Morales-Garcia JA, Santos A and Perez-Castillo A: CCAAT/enhancer binding protein β induces motility and invasion of glioblastoma cells through transcriptional regulation of the calcium binding protein S100A4. Oncotarget. 6:4369–4384. 2015. View Article : Google Scholar : PubMed/NCBI
23	Gomis RR, Alarcón C, Nadal C, Van Poznak C and Massagué J: C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell. 10:203–214. 2006. View Article : Google Scholar : PubMed/NCBI
24	Park BH, Kook S, Lee S, Jeong JH, Brufsky A and Lee BC: An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration. J Biol Chem. 288:28656–28667. 2013. View Article : Google Scholar : PubMed/NCBI
25	Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, et al: Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas. Oncotarget. 6:16106–16119. 2015. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Lin SS, Peng CY, Liao YW, Chou MY, Hsieh PL and Yu CC: miR-1246 targets CCNG2 to enhance cancer stemness and chemoresistance in oral carcinomas. Cancers (Basel). 10(pii): E2722018. View Article : Google Scholar : PubMed/NCBI
28	Chen M, Wu L, Tu J, Zhao Z, Fan X, Mao J, Weng Q, Wu X, Huang L, Xu M and Ji J: miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression. EBioMedicine. 35:142–154. 2018. View Article : Google Scholar : PubMed/NCBI
29	Anand S, Ebner J, Warren CB, Raam MS, Piliang M, Billings SD and Maytin EV: C/EBP transcription factors in human squamous cell carcinoma: Selective changes in expression of isoforms correlate with the neoplastic state. PLoS One. 9:e1120732014. View Article : Google Scholar : PubMed/NCBI
30	Yang X, Du T, Wang X, Zhang Y, Hu W, Du X, Miao L and Han C: IDH1, a CHOP and C/EBPβ-responsive gene under ER stress, sensitizes human melanoma cells to hypoxia-induced apoptosis. Cancer Lett. 365:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
31	Yan Y, Hanse EA, Stedman K, Benson JM, Lowman XH, Subramanian S and Kelekar A: Transcription factor C/EBP-β induces tumor-suppressor phosphatase PHLPP2 through repression of the miR-17-92 cluster in differentiating AML cells. Cell Death Differ. 23:1232–1242. 2016. View Article : Google Scholar : PubMed/NCBI